Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens? - Test2 - elhamkhani - TriplyDB

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

http://www.wikidata.org/entity/Q38040818

about

Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain The trans-kingdom identification of negative regulators of pathogen hypervirulence Naloxonazine, an Amastigote-Specific Compound, Affects Leishmania Parasites through Modulation of Host-Encoded Functions Fitness of Leishmania donovani parasites resistant to drug combinations Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent LC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test case.Transmission potential of antimony-resistant leishmania field isolates Correlation between glucose uptake and membrane potential in Leishmania parasites isolated from DCL patients with therapeutic failure: a proof of concept.Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1.Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hosts.Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure.Evaluating drug resistance in visceral leishmaniasis: the challenges.Evaluation of Correlation between the In Vitro Susceptibility of Field Isolates of Leishmania major and Clinical Outcomes of Meglumine Antimoniate Therapy in Fars Province, Iran.Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum.

P2860

Q24611966-2E8C363F-28A0-4E43-8978-B5BB321743B4 Q26782915-66CDE3E1-D7AD-4B75-8BF1-03E90BE0D479 Q28468455-766C469A-0004-426C-B397-E92E5FABAA55 Q28545794-BC59CA36-EE2C-4D9A-BEE3-C51362E9A8BB Q28546940-8E7EC450-3427-4747-B670-CF0702DAEB1B Q28550306-0B3F0EE6-C36F-4AE0-9F41-7255B2DB8467 Q28551055-0E28B34E-09EE-4468-AEBD-7D0FF5C3B344 Q30790484-AA46DD60-CCF8-447C-8C14-500B4C8C6CEB Q34299023-7C0B6A2E-EC4B-4109-A87E-54C027BD94DA Q34660710-520BC203-7B72-4AB9-BC38-4034212DF4E8 Q36616938-CB13C4BA-AD77-4F20-90C8-3E690C4EF2A4 Q38209866-ACCB4D1D-29E6-4B3B-B0DE-D509B58FC118 Q38892717-0C88D73D-05E3-4D01-94A8-06BC3F7A9DE6 Q38904947-3FD12E53-FE2E-4689-92ED-F856EC0EDE55 Q39014583-A7A37381-41B1-495F-B647-F296F2067CC7 Q42277296-07640B21-A477-466C-9712-D523708181B3 Q42548785-FD707162-3808-448E-9281-F019D6790581 Q53120855-9840E559-65E2-46E9-87D4-525EA6E7D4A9

P2860

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

http://www.wikidata.org/entity/Q38040818

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

@en

type

label

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

@en

prefLabel

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

@en

P1433

Q38040818-3094F5A5-AE99-49ED-A7C5-DA58FD51F559

P1476

Q38040818-FC3A29DD-EF65-4CA6-BB42-C7A105E5424B

P2093

Q38040818-0B7397BD-0F8E-4567-9BAB-044BB2C598E4

Q38040818-366A7B20-C43A-4519-92EB-C2D798E7F6DB

Q38040818-815D4ADF-833A-4AC7-9151-DCC18347A54F

P2860

Q38040818-013D3D2F-25F8-4588-A76C-C9C2541782A9

Q38040818-018EAC09-F4FB-4B56-A7D0-B6CFBD9D72F7

Q38040818-0568DE8D-1F76-47FF-BF2F-205FDF4C3362

Q38040818-0807A2A9-97F5-4BBB-B29D-D9EDD13E0F0F

Q38040818-0848F7AF-9B7B-45FA-BF6E-497FD4F97801

Q38040818-0E1222D3-30D3-47C9-B5C5-56EBD77787C8

Q38040818-10623C2F-CF5B-47B0-9B04-50D546EAF0CD

Q38040818-1363E92B-E948-487D-8639-8F01C3ACA4FA

Q38040818-15A2A789-47D6-43E6-969D-783299371C0F

Q38040818-15C93188-607F-4F3E-B6B0-FBC1ECF4B11E

P304

Q38040818-72938E0E-888B-49DA-9641-6A13DCA37F21

P31

Q38040818-A9631148-702D-4F5D-90DB-ACE1BE9FC459

P356

Q38040818-03FF7AE6-5177-407D-A692-B9459F23C030

P407

Q38040818-8BA502A7-0115-4B8B-91DD-DE9903676DAE

P433

Q38040818-F9C40C76-8262-4C71-A535-1D5B9DBC9D46

P478

Q38040818-80F2392A-8363-46A0-95FB-5D55775A80E8

P50

Q38040818-259E2401-5742-4F0C-8E33-A8370C7C7711

Q38040818-E7D13E8F-EE29-40CE-B405-2DF0F15ED53C

P577

Q38040818-F056F427-C81F-47E1-BA68-1A466FC56810

P698

Q38040818-10FE0901-44A0-4DE0-909A-90F0395F5334

P356

1040841X.2012.716818

P1433

Critical Reviews in Microbiology

P1476

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

@en

P2093

Jean-Claude Dujardin

http://www.w3.org/2001/XMLSchema#string

Maya Berg

http://www.w3.org/2001/XMLSchema#string

Syamal Roy

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif

Fitness and its role in evolutionary genetics

Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania

Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance

Molecular basis of antimony treatment in leishmaniasis

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani

Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism

Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis

Sodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human blood

P304

384-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1040841X.2012.716818

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Manu Vanaerschot

Saskia Decuypere

P577

2012-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22950457

http://www.w3.org/2001/XMLSchema#string